Codes / ICD10CM / C83.72

C83.72 Burkitt lymphoma, intrathoracic lymph nodes

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Burkitt lymphoma, intrathoracic lymph nodes
  • Medical term: Burkitt's lymphoma

Summary

Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma that primarily affects B-cells in the lymphatic system. This subtype involves the intrathoracic lymph nodes, which include those in the chest cavity. It is characterized by rapid tumor growth and is often associated with specific genetic and viral factors. Early diagnosis and treatment are critical due to its fast progression.

Causes

The exact causes of Burkitt lymphoma are not fully understood, but it is strongly linked to infection with the Epstein-Barr virus (EBV). Genetic mutations, particularly chromosomal translocations involving the MYC gene, are also key contributors to its development.

Risk Factors

  • Epstein-Barr virus (EBV) infection
  • Human immunodeficiency virus (HIV) infection
  • Weakened immune system from other conditions or treatments
  • Young age, especially in children and young adults
  • Geographic regions with high EBV prevalence, such as equatorial Africa

Symptoms

  • Rapidly growing, painless lymph node swelling in the chest area
  • Chest pain or discomfort
  • Difficulty breathing or shortness of breath
  • Fever
  • Night sweats
  • Unexplained weight loss
  • Fatigue

Diagnosis

Diagnosis involves a physical examination to assess lymph node or organ swelling, followed by imaging tests (e.g., CT or MRI) to identify tumor locations in the chest. A biopsy of affected tissue is performed to confirm the presence of cancerous cells and determine the specific subtype.

Treatment Options

Treatment typically involves intensive chemotherapy regimens, often combined with immunotherapy or targeted therapies. Radiation therapy may be used in specific cases to address localized disease. Treatment plans are tailored to the patient's overall health and disease stage.

Prognosis and Follow-Up

With prompt and appropriate treatment, the prognosis for Burkitt lymphoma can be favorable, especially in younger patients. Regular follow-up appointments, including imaging and blood tests, are essential to monitor for recurrence or complications.

Complications

Potential complications include tumor lysis syndrome, infection due to weakened immunity, and organ dysfunction from tumor pressure or invasion. Early intervention can help mitigate these risks.

Lifestyle & Prevention

Maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., unprotected exposure to EBV) may support overall health. However, no specific prevention methods exist for this condition.

When to Seek Professional Help

Seek immediate medical attention if you experience persistent chest pain, difficulty breathing, unexplained weight loss, or rapidly enlarging lymph nodes. Early evaluation is critical for effective management.

Tips for Medical Coders

When coding for Burkitt lymphoma involving intrathoracic lymph nodes, use C83.72. Ensure documentation specifies the intrathoracic location to support accurate code assignment. Verify that the diagnosis aligns with clinical findings and that any relevant staging or treatment details are clearly recorded.

Book a walkthrough

C83.72 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.